# Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial

> **NCT01995942** · — · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 246 (actual)

## Conditions studied

- Adenocarcinoma
- Rectal Diseases
- Colorectal Neoplasms
- Adenocarcinoma, Mucinous
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms, Cystic, Mucinous, and Serous
- Intestinal Neoplasms
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Neoplasms by Site
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01995942
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06-07
- **Primary completion:** 2017-02-02
- **Final completion:** 2022-02-02
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2018-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01995942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01995942, "Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01995942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*